Primary Site >> Pancreatic Cancer
Gene >> SLC5A8
| 1. | |||||||||||
| Journal: | Br J Surg. 2000 Jan;87(1):43-8. | ||||||||||
| Title: | Effect of intraportal adoptive immunotherapy on liver metastases after resection of pancreatic cancer. | ||||||||||
| Author: | Kobari, M|Egawa, S|Shibuya, K|Sunamura, M|Saitoh, K|Matsuno, S | ||||||||||
| PMID: | 10606909 | ||||||||||
| 2. | |||||||||||
| Journal: | Pancreas. 2008 May;36(4):e32-9. | ||||||||||
| Title: | Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer. | ||||||||||
| Author: | Park, Jong Y|Helm, James F|Zheng, Weipeng|Ly, Quan P|Hodul, Pamela J|Centeno, Barbara A|Malafa, Mokenge P | ||||||||||
| PMID: | 18437076 | ||||||||||
| 3. | |||||||||||
| Journal: | Oncol Rep. 2008 Jul;20(1):155-63. | ||||||||||
| Title: | Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1. | ||||||||||
| Author: | Kawaoka, Toru|Oka, Masaaki|Takashima, Motonari|Ueno, Tomio|Yamamoto, Koutaro|Yahara, Noboru|Yoshino, Shigefumi|Hazama, Shoichi | ||||||||||
| PMID: | 18575732 | ||||||||||
| 4. | |||||||||||
| Journal: | Biol Pharm Bull. 2010;33(10):1740-5. | ||||||||||
| Title: | Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. | ||||||||||
| Author: | Liu, Tianyou|Song, Yan|Chen, Hua|Pan, Shangha|Sun, Xueying | ||||||||||
| PMID: | 20930385 | ||||||||||
| 5. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2011 Jun 29;30:66. | ||||||||||
| Title: | Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. | ||||||||||
| Author: | Ling, Qi|Xu, Xiao|Wei, Xuyong|Wang, Weibing|Zhou, Bin|Wang, Bei|Zheng, Shusen | ||||||||||
| PMID: | 21714853 | ||||||||||
| 6. | |||||||||||
| Journal: | Pancreas. 2012 Aug;41(6):904-9. | ||||||||||
| Title: | SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. | ||||||||||
| Author: | Helm, James|Coppola, Domenico|Ganapathy, Vadivel|Lloyd, Mark|Centeno, Barbara A|Chen, Dung-Tsa|Malafa, Mokenge P|Park, Jong Y | ||||||||||
| PMID: | 22450368 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncol Rep. 2013 Aug;30(2):589-95. | ||||||||||
| Title: | Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-kappaB-mediated VEGF signaling pathway. | ||||||||||
| Author: | Chen, Hui|Zhang, Jianhong|Luo, Jiang|Lai, Fuji|Wang, Zhaohong|Tong, Hongfei|Lu, Dian|Bu, Heqi|Zhang, Riyuan|Lin, Shengzhang | ||||||||||
| PMID: | 23754270 | ||||||||||
| 8. | |||||||||||
| Journal: | J Transl Med. 2014 Jun 19;12:175. | ||||||||||
| Title: | Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer. | ||||||||||
| Author: | Shindo, Yoshitaro|Hazama, Shoichi|Maeda, Yoshinari|Matsui, Hiroto|Iida, Michihisa|Suzuki, Nobuaki|Yoshimura, Kiyoshi|Ueno, Tomio|Yoshino, Shigefumi|Sakai, Kohei|Suehiro, Yutaka|Yamasaki, Takahiro|Hinoda, Yuji|Oka, Masaaki | ||||||||||
| PMID: | 24947606 | ||||||||||
| 9. | |||||||||||
| Journal: | Anticancer Res. 2016 May;36(5):2307-13. | ||||||||||
| Title: | A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic Cancer. | ||||||||||
| Author: | Yamaguchi, Yoshiyuki|Katata, Yousuke|Okawaki, Makoto|Sawaki, Akira|Yamamura, Masahiro | ||||||||||
| PMID: | 27127137 | ||||||||||
| 10. | |||||||||||
| Journal: | Am J Physiol Cell Physiol. 2016 Nov 1;311(5):C720-C734. | ||||||||||
| Title: | Insulin and SGK1 reduce the function of Na+/monocarboxylate transporter 1 (SMCT1/SLC5A8). | ||||||||||
| Author: | Lopez-Barradas, Adriana|Gonzalez-Cid, Tania|Vazquez, Norma|Gavi-Maza, Marisol|Reyes-Camacho, Adriana|Velazquez-Villegas, Laura A|Ramirez, Victoria|Zandi-Nejad, Kambiz|Mount, David B|Torres, Nimbe|Tovar, Armando R|Romero, Michael F|Gamba, Gerardo|Plata, Co | ||||||||||
| PMID: | 27488665 | ||||||||||
| 11. | |||||||||||
| Journal: | Pancreas. 2017 Sep;46(8):994-1002. | ||||||||||
| Title: | Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy. | ||||||||||
| Author: | Matsui, Hiroto|Hazama, Shoichi|Sakamoto, Kazuhiko|Shindo, Yoshitaro|Kanekiyo, Shinsuke|Nakashima, Masao|Matsukuma, Satoshi|Tokuhisa, Yoshihiro|Iida, Michihisa|Suzuki, Nobuaki|Yoshimura, Kiyoshi|Takeda, Shigeru|Ueno, Tomio|Yoshino, Shigefumi|Oka, Masaaki|N | ||||||||||
| PMID: | 28697053 | ||||||||||
| 12. | |||||||||||
| Journal: | Mol Oncol. 2018 Jun;12(7):1203-1215. | ||||||||||
| Title: | Matrine suppresses KRAS-driven pancreatic cancer growth by inhibiting autophagy-mediated energy metabolism. | ||||||||||
| Author: | Cho, Young-Ra|Lee, Ji Hyeon|Kim, Ji Hye|Lee, So-Yeon|Yoo, Suna|Jung, Min-Kyo|Kim, Su Jung|Yoo, Hyun Ju|Pack, Chang-Gi|Rho, Jin Kyung|Son, Jaekyoung | ||||||||||
| PMID: | 29791786 | ||||||||||